@newsramp.comFamiCord's Bramble Bio has signed a manufacturing deal with VERIGRAFT to produce personalized tissue-engineered vein P-TEV for the pivotal Phase II/III trial TECVI-2, valued in the low single-digit millions of euros. Trial expected to begin Q1 2027. #CDMO #CellTherapy
@dominic-tyer.bsky.socialModerna outlined its COVID-era manufacturing lessons and how the biotech works with CDMOs at CPHI Milan this week
@aganitha.aiMuch of the scientific and technical work around #CDMO selection in a #Biopharma still happens outside ERP & procurement systems - in PDFs, spreadsheets, emails & manual reviews.
At Aganitha, we are using #AI to streamline these workflows.
Know more at www.aganitha.ai/blogs/cdmo-g...
@outsourcedpharma.bsky.socialBluesky
RNA therapeutics are advancing fast. The outsourcing ecosystem has to keep up.
Chief Editor Louis Garguilo looks at how CDMOs, academia, automation and new service models could reshape RNA development and manufacturing.
www.outsourcedpharma.com/doc/cdmos-co...
#RNA #CDMO #Biopharma
@newsen.bsky.socialROIS Unveils New Brand Identity at CPHI Milan 2026 Event #Italy #Milan #CDMO #ROIS #CPHI_Milan
@newsen.bsky.socialROIS Unveils New Brand Identity and Website at CPHI Milan 2026 #Italy #Milan #CDMO #ROIS #CPHI_Milan
@new3rd.bsky.social@newsen.bsky.socialAjinomoto Bio-Pharma Services Launches a Renewed Global Brand Focused on Specialization #Japan #Tokyo #CDMO #Ajinomoto #Bio-Pharma_Services
@outsourcedpharma.bsky.socialYour CDMO can make the product. But can the market afford it?
@drjbug.bsky.social examines why affordability should shape formulation, packaging and outsourcing decisions long before launch.
www.outsourcedpharma.com/doc/your-cdm...
#CDMO #Biopharma #pharmamanufacturing
@outsourcedpharma.bsky.socialJoin me tomorrow for a great, live discussion!
Complimentary registration, thanks to Douglas Pharmaceuticals:
event.on24.com/wcc/r/547759...
@nikolospharma.bsky.social
@nikolospharma.bsky.social
@nikolospharma.bsky.social
@nikolospharma.bsky.social
@nikolospharma.bsky.social
@outsourcedpharma.bsky.socialStay ahead of what’s shaping biopharma outsourcing. Get free industry news, expert perspectives, and practical insights from Outsourced Pharma.
Sign up for free: www.outsourcedpharma.com/user/new
@3d-biotissues.bsky.socialSurviving the thaw is only the first step.
Viability alone doesn’t show how consistently cells attach, regain morphology and return to productive growth. CytoBoost™ REVIVE supports stronger post-thaw recovery.
Talk to Adam: [email protected]
@nikolospharma.bsky.social
@narrowit.bsky.socialMade Scientific Buys Pennsylvania Cell-Therapy Plant Made Scientific acquired an operating 85,000-square-foot cell-therapy manufacturing facility...
https://www.narrowit.com/news/made-scientific-pennsylvania-cell-therapy-facility-2026-09-21
#MadeScientific #NationalResilience #CellTherapy #CDMO
@nikolospharma.bsky.social